283 related articles for article (PubMed ID: 20629512)
1. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
2. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
4. [A practical guide for the management of gliomas].
Stupp R; Pica A; Mirimanoff RO; Michielin O
Bull Cancer; 2007 Sep; 94(9):817-22. PubMed ID: 17878102
[TBL] [Abstract][Full Text] [Related]
5. Molecular biomarkers in pediatric glial tumors: a needed wind of change.
Fontebasso AM; Bechet D; Jabado N
Curr Opin Oncol; 2013 Nov; 25(6):665-73. PubMed ID: 24097106
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
7. Genetic markers in adult high-grade gliomas.
Pekmezci M; Perry A
Semin Radiat Oncol; 2014 Oct; 24(4):235-9. PubMed ID: 25219807
[TBL] [Abstract][Full Text] [Related]
8. Beyond grade: molecular pathology of malignant gliomas.
Sulman EP; Guerrero M; Aldape K
Semin Radiat Oncol; 2009 Jul; 19(3):142-9. PubMed ID: 19464628
[TBL] [Abstract][Full Text] [Related]
9. Diffusely infiltrative low-grade gliomas in adults.
Lang FF; Gilbert MR
J Clin Oncol; 2006 Mar; 24(8):1236-45. PubMed ID: 16525178
[TBL] [Abstract][Full Text] [Related]
10. Genetics, prognosis and therapy of central nervous system tumors.
Watkins D; Rouleau GA
Cancer Detect Prev; 1994; 18(2):139-44. PubMed ID: 8025896
[TBL] [Abstract][Full Text] [Related]
11. Molecular changes in brain tumors: prognostic and therapeutic impact.
Sanson M; Laigle-Donadey F; Benouaich-Amiel A
Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic markers in gliomas - an update.
Ma R; de Pennington N; Hofer M; Blesing C; Stacey R
Br J Neurosurg; 2013 Jun; 27(3):311-5. PubMed ID: 23278177
[TBL] [Abstract][Full Text] [Related]
13. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].
Idoate MA; Echeveste J
Rev Neurol; 2007 Feb 16-28; 44(4):217-24. PubMed ID: 17311212
[TBL] [Abstract][Full Text] [Related]
14. Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.
Schiff D; Brown PD; Giannini C
Neurology; 2007 Sep; 69(13):1366-73. PubMed ID: 17893297
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
[TBL] [Abstract][Full Text] [Related]
16. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
17. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
18. Glioma diagnosis: immunohistochemistry and beyond.
Dunbar E; Yachnis AT
Adv Anat Pathol; 2010 May; 17(3):187-201. PubMed ID: 20418673
[TBL] [Abstract][Full Text] [Related]
19. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
20. Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence.
Rickert CH; Paulus W
Acta Neuropathol; 2005 Jan; 109(1):69-92. PubMed ID: 15647946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
